Viewing Study NCT02533258


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-03-06 @ 6:11 PM
Study NCT ID: NCT02533258
Status: COMPLETED
Last Update Posted: 2025-07-16
First Post: 2015-08-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12-02
Start Date Type: ACTUAL
Primary Completion Date: 2016-05-12
Primary Completion Date Type: ACTUAL
Completion Date: 2016-05-12
Completion Date Type: ACTUAL
First Submit Date: 2015-08-24
First Submit QC Date: None
Study First Post Date: 2015-08-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-05-11
Results First Submit QC Date: None
Results First Post Date: 2017-10-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-15
Last Update Post Date: 2025-07-16
Last Update Post Date Type: ACTUAL